A Randomized, Double-blind, Placebo-controlled, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Danavorexton in Anesthetized Adults
Latest Information Update: 19 May 2022
At a glance
- Drugs Danavorexton (Primary) ; Propofol; Sevoflurane
- Indications Hypersomnia; Narcolepsy; Sleep apnoea syndrome
- Focus Adverse reactions
- Sponsors Takeda
- 06 May 2022 Status changed from recruiting to completed.
- 15 Mar 2022 Planned End Date changed from 8 Feb 2022 to 8 Apr 2022.
- 15 Mar 2022 Planned primary completion date changed from 8 Feb 2022 to 8 Apr 2022.